... regimens used The studies investigated a variety of combination chemotherapy regimens over the period 1980 to 2008 (see Table ... Unknown Primary Site - A Randomized Study of 2 Combination Chemotherapy Regimens. European Journal of Cancer & Clinical Oncology. 1987; 23 ( ...

... with platinum and etoposide, compared with the same combination chemotherapy regimen alone. (Refer to the Combination chemotherapy section of ... patients with either LD or ED. Evidence (other combination chemotherapy regimens): Irinotecan. Five trials and two meta-analyses have ...

... 9649162 ] Woods RL. A randomized study of two combination-chemotherapy regimens. New England Journal of Medicine. 1980; 303 (2): ... 1980. Woods RL. A randomized study of two combination-chemotherapy regimens. New England Journal of Medicine. 1980; 303 (2): ...

... with the addition of carboplatin to anthracycline-taxane combination chemotherapy regimens in patients with triple-negative breast cancer (TNBC). ... node-positive, as part of a complete treatment regimen and in combination with chemotherapy and trastuzumab as adjuvant treatment for HER2-positive ...

... superior to a number of other, more intensive, combination chemotherapy regimens. With improvement in diagnostics, T-cell lymphomas could ... Gemcitabine is an attractive drug to use in combination for PTCL, because it is ... containing chemotherapy regimens are effective (such as GEM-P) but other ...

... with germ cell tumors receiving 5-day cisplatin combination chemotherapy regimens: a hoosier oncology group study. J Clin Oncol ... dose at 1.5 mg. Multiagent single-day chemotherapy ... basing the emetogenicity of combination antineoplastic regimens on that of the agent of ...

... patient population of interest involving various single and combination chemotherapy regimens. Based on this review, members of the guideline ... acquisition cost per cycle was calculated for each chemotherapy regimen ... cycle for combination therapy and continuous infusion for 5-FU ( Table ...

... to reduce gonadal toxicity and enhance antineoplastic activity. Combination chemotherapy regimens used in trials are summarized in Table 5 . ... or etoposide) as an alternative to alkylating-agent chemotherapy results in an inferior EFS ... (VAMP) is an effective regimen (10-year EFS, 89%) for favorable-risk (low- ...

... additional chemotherapy, TACE, or radiation therapy. The standard combination chemotherapy regimen in North America is four courses of cisplatin/ ...